[EN] ALISKIREN MODULATION OF NEUROGENESIS<br/>[FR] MODULATION DE LA NEUROGENÈSE AVEC L'ALISKIREN
申请人:BRAINCELLS INC
公开号:WO2010111136A2
公开(公告)日:2010-09-30
The disclosure provides compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis by use of a renin inhibitor in combination with one or more neurogenic agents. The disclosure also includes compositions and methods for stimulating or activating the formation of new nerve cells based on the application of a renin inhibitor in combination with one or more neurogenic agents.